Apollo Health Ventures raised $180 million for a new venture capital fund focused on biotechnology companies developing therapies for age-related diseases. It may also invest in healthtech and digital health opportunities, but the latter constitute a minority pursuit for an investment team that is building up capabilities and expertise in disease biology.

Biopharmas raising money in public or private financings, including: Aditxt, Amarna, Biovie, Curie, Immunogen, Itabmed, Krystal, Longeveron, MEI, Regulus, TLGY, Trefoil.

Biopharmas raising money in public or private financings, including: Beigene, Clairvoyant, Everimmune, Krystal, Mana, Outlook, Pasithea, Petros, Qualigen, Scirhom.

Biopharmas raising money in public or private financings, including: Ablaze, Biofrontera, Genenta, Help, Hotspot, Lysogene, Nervgen, Northwest, Regulus, Valeo.

Biopharmas raising money in public or private financings, including: Allorion, Forbion, Incannex, Outlook, Pasithea, Redhill, Seelos, Valeo.

Biopharmas raising money in public or private financings, including: Beigene, Bionomics, Greenlight, Neurophth, Theratechnologies.